FlowMedica, Inc., of Fremont, Calif., announced that it has received clearance for a new labeling indication for its Benephit Infusion Systems, which can now facilitate targeted renal therapy (TRT) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results